GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OTCPK:NVZMF) » Definitions » Cyclically Adjusted PB Ratio

NVZMF (Novonesis (Novozymes) B) Cyclically Adjusted PB Ratio : 8.49 (As of May. 30, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis (Novozymes) B Cyclically Adjusted PB Ratio?

As of today (2025-05-30), Novonesis (Novozymes) B's current share price is $68.832. Novonesis (Novozymes) B's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $8.11. Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio for today is 8.49.

The historical rank and industry rank for Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio or its related term are showing as below:

NVZMF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.23   Med: 9.5   Max: 13.83
Current: 8.22

During the past years, Novonesis (Novozymes) B's highest Cyclically Adjusted PB Ratio was 13.83. The lowest was 6.23. And the median was 9.50.

NVZMF's Cyclically Adjusted PB Ratio is ranked worse than
93.08% of 1142 companies
in the Chemicals industry
Industry Median: 1.58 vs NVZMF: 8.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Novonesis (Novozymes) B's adjusted book value per share data for the three months ended in Mar. 2025 was $26.043. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $8.11 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Chart

Novonesis (Novozymes) B Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.43 13.63 7.97 8.23 7.78

Novonesis (Novozymes) B Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.23 - 8.70 7.78 7.14

Competitive Comparison of Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio falls into.


;
;

Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=68.832/8.11
=8.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Novonesis (Novozymes) B's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=26.043/120.2000*120.2000
=26.043

Current CPI (Mar. 2025) = 120.2000.

Novonesis (Novozymes) B Quarterly Data

Book Value per Share CPI Adj_Book
201503 5.299 100.200 6.357
201506 5.496 100.300 6.586
201509 5.480 100.200 6.574
201512 5.571 99.800 6.710
201603 5.248 100.200 6.296
201606 5.505 100.600 6.578
201609 5.527 100.200 6.630
201612 5.595 100.300 6.705
201703 5.297 101.200 6.291
201706 5.458 101.200 6.483
201709 5.869 101.800 6.930
201712 6.107 101.300 7.246
201803 5.783 101.700 6.835
201806 5.778 102.300 6.789
201809 5.921 102.400 6.950
201812 6.052 102.100 7.125
201903 5.738 102.900 6.703
201906 5.841 102.900 6.823
201909 5.828 102.900 6.808
201912 6.062 102.900 7.081
202003 5.647 103.300 6.571
202006 5.823 103.200 6.782
202009 6.121 103.500 7.109
202012 6.574 103.400 7.642
202103 6.181 104.300 7.123
202106 6.366 105.000 7.288
202109 6.609 105.800 7.509
202112 6.484 106.600 7.311
202203 6.040 109.900 6.606
202206 6.221 113.600 6.582
202209 6.579 116.400 6.794
202212 7.112 115.900 7.376
202303 6.692 117.300 6.857
202306 7.030 116.400 7.260
202309 7.465 117.400 7.643
202312 7.376 116.700 7.597
202403 0.000 118.400 0.000
202406 25.507 118.500 25.873
202412 25.106 118.900 25.380
202503 26.043 120.200 26.043

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novonesis (Novozymes) B  (OTCPK:NVZMF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines